The nation’s largest retail pharmacy, CVS, announced on Wednesday, November 28, it had completed a US$69 billion acquisition of health insurance giant Aetna, CNBC reported.
“Today marks the start of a new day in health care and a transformative moment for our company and our industry,” CVS Health president and CEO Larry Merlo said in a statement.
Merlo said in a statement earlier this month that the deal will create new ways for the companies to engage patients’ total health care needs, with added convenience and lower costs.
“Our focus will be at the local and community level, taking advantage of our thousands of locations and touchpoints throughout the country to intervene with consumers to help predict and prevent potential health problems before they occur,” he said, adding that Aetna would continue to operate as a standalone company within CVS.
As part of the deal, Aetna agreed to sell all of its Medicare prescription drug plans to WellCare Health Plans.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI